A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d...

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Oncomirs are microRNAs (miRNAs) with roles in cancer development, acting as oncogenes or tumor suppressors.
• Identifying novel oncomirs is crucial for advancing cancer diagnostics and therapeutics.
• Current methods for oncomir discovery face significant challenges.

Purpose of the Study:

• To develop and validate a novel, clinically guided genetic screening approach for identifying oncomirs.
• To identify specific oncomirs implicated in human solid tumors using this new strategy.
• To investigate the functional roles and clinical relevance of identified oncomirs.

Main Methods:

• Implementation of a clinically guided genetic screening strategy.
• Identification of microRNA-30d (mir-30d) as a candidate oncomir.
• Analysis of mir-30d expression and chromosomal locus amplification in human solid tumors (n=1,283).
• Correlation of mir-30d expression with clinical outcomes in ovarian cancer patients (n=330).
• Mechanistic studies investigating mir-30d's regulation of cancer-associated genes, including CASP3.

Main Results:

• The novel screening approach successfully identified mir-30d.
• The chromosomal locus of mir-30d was amplified in over 30% of analyzed solid tumors.
• Elevated mir-30d expression significantly correlated with poor prognosis in ovarian cancer patients (P=0.0016).
• mir-30d was shown to regulate tumor cell proliferation, apoptosis, senescence, and migration.
• mir-30d targets numerous cancer-associated genes, including the apoptotic gene CASP3.

Conclusions:

• The developed guided genetic screening approach is a powerful tool for oncomir discovery.
• mir-30d is a significant oncomir implicated in multiple human solid tumors.
• mir-30d holds potential as a prognostic biomarker and a therapeutic target in cancer treatment.